Combined capacity utilisation at all-India level is 60-70% – higher than in most other industries
The pharma industry in India is pulling out all the stops to ensure that the production of medicines, essential in fighting the coronavirus pandemic, does not suffer. In an unprecedented move, all major companies have come together to help one another with knowledge and sharing resources.
Capacity utilisation at an all-India level, relating to both small and big manufacturers, is 60-70 per cent, which is higher than in most other industries.
You might also be interested to read: Coronavirus Outbreak Pushes Up Demand For Scenario Planning By IT Firms
The Indian Pharmaceutical Alliance (IPA), the lobby group that represents India’s top 25 giants, has said the biggest companies are able to operate normally despite the crisis. Almost all the major drug firms have their units in Sikkim, where plants are operating at full capacity, industry said.
Pankaj Patel, chairman of Cadila Healthcare, said production in Sikkim was normal. Similarly, for Alembic Pharma, its Sikkim plant is operating in full swing.
Source: Business Standard
